Associate Clinical Professor and Director of Strategic Operations Auburn University Harrison School of Pharmacy Kimberly, Alabama
Disclosure(s): No relevant financial relationship(s) to disclose.
Disclosure(s):
Marilyn N. Bulloch, PharmD, BCPS, FCCM: No relevant financial relationship(s) to disclose.
This session will focus on the management of influenza in the critically ill. In particular, the session will discuss how to manage influenza that has undergone antigenic drift or shift that has resulted in decreased, minimal, or no vaccine or natural immunity protection and subsequently resulted an epidemic or pandemic with a surge of critically ill patients. The session will discuss the basic science for why these changes occur, best practices and lessons learned from previous epidemics or pandemics, and evidence based and targeted approaches to containment and management of the viral infection. The session will also evaluate influenza viruses of interest that are considering emerging threats or to have pandemic potential in humans. Dr. Bulloch is considered a thought leader in the area of influenza and has presented numerous presentations nationwide on influenza and its management.
Presentations in this session: When flu is new: dealing with epidemic or pandemic influenza in the ICU - Marilyn N. Bulloch, PharmD, BCPS, FCCM New(-ish) and unfamiliar viruses: when scary viruses appear in the ICU - Adrienne Randolph, MD, MS, FCCM Resurgence of old viruses: vaccine preventable infections in the critically ill - Ryan Maves, MD, FCCM
